New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

To the editor: The risk for a hepatitis C virus (HCV) RNA–positive donor to transmit the virus to the recipient through a hematopoietic stem cell transplantation (HSCT) is constant.[1][1] Although this situation is not an absolute contraindication to donation from an HLA-identical sibling,[2][2